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Abstract
This report is the first to demonstrate infection of human endothelial cells by Pichinde virus (PIC).
PIC infection induces an upregulation of the inducible nitric oxide synthase gene; as well as an
increase in detectable nitric oxide (NO). PIC induces an increase in permeability in endothelial cell
monolayers which can be abrogated at all measured timepoints with the addition of a nitric oxide
synthase inhibitor, indicating a role for NO in the alteration of endothelial barrier function. Because
NO has shown antiviral activity against some viruses, viral titer was measured after addition of the
NO synthase inhibitor and found to have no effect in altering virus load in infected EC. The NO
synthase inhibition also has no effect on levels of activated caspases induced by PIC infection. Taken
together, these data indicate NO production induced by Pichinde virus infection has a pathogenic
effect on endothelial cell monolayer permeability.
Introduction
Several members of the Arenaviridae family are the agents
responsible for hemorrhagic fevers. These members
include Junin virus, Machupo virus, and Lassa virus; the
etiological agents of Argentine hemorrhagic fever (AHF),
Bolivian hemorrhagic fever (BHF), and Lassa fever (LF),
respectively [1]. Pichinde virus (PIC) belongs to the New
World arenavirus complex along with Junin and Machupo
[2]. However, unlike Junin and Machupo, PIC is not a
human pathogen and therefore does not require high con-
tainment facilities to work with this virus. Due to this fact,
other groups have used PIC as a model virus for arenavirus
infection. Guinea pig infection with PIC has shown path-
ological similarities with LF, further supporting its use as
a model for human Lassa fever [3].
The hallmark of infection by hemorrhagic fever viruses is
the induction of vascular leak, or the breakdown of
endothelial cell barrier function [4]. Endothelial cells are
critical to vascular integrity by providing both structure
and regulation of immune cells, solutes, and water across
the barrier [5]. Vascular leak can be caused by direct viral
effects that alter barrier integrity, the induction of apopto-
sis of the endothelium, or indirectly through the effects of
soluble mediators such as pro-inflammatory cytokines
created by the host immune response [4]. TNF-α and IFN-
γ have been shown previously to induce vascular leak in a
transendothelial resistance assay [6].
In general, arenaviruses are not highly cytopathic viruses
in vitro or  in vivo [7-9]. Therefore, it is believed that
immune mediators play a significant role in endothelial
cell barrier function. Previous studies of PIC have shown
elevated levels of proinflammatory cytokines, such as
TNF-α, during the course of infection of guinea pigs [10].
TNF-α has also been noted in Argentine hemorrhagic
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fever patients [11,12]. Other inflammatory mediators
such as IL-8, IFN-γ, IL-12, IL-6, IP-10, and RANTES have
been noted in the serum of LF patients [13].
Nitric oxide (NO) is a free radical with diverse physiolog-
ical functions in humans. NO is a critical component of
the innate immune response to various pathogens such as
bacteria, parasites, and viruses including influenza A virus
and coxsackie virus [14]. In addition to its role as in anti-
microbial defense, NO has key roles in regulation of
endothelial cell barrier function. Basal levels of NO are
necessary for vasodilation, platelet aggregation, and the
modulation of inflammatory cell adhesion to the
endothelium [14-16]. The effects of NO on the cardiovas-
cular system are dependent upon the amount of NO pro-
duced, the local environment, and redox state of NO.
While low levels of NO are necessary for the integrity of
the endothelium, excessive amounts of NO are patho-
genic leading to compromised barrier function [17].
NO production has been noted in virulent Junin virus
infection of endothelial cells in vitro. Serum samples from
AHF patients confirm the increase in NO in vivo. By com-
paring these results to endothelial cells infected with non-
virulent Junin virus, Gomez, et al, hypothesized that the
increased production of NO was a contributing factor to
the pathogenesis of AHF [18].
This study evaluated the potential of PIC to infect and
induce permeability in human endothelial cell monolay-
ers. The ability of PIC to induce the production of NO and
TNF-α in response to viral infection; correlating with the
induction of vascular leak was also determined. Inhibitors
of vascular leak were evaluated for their ability to alter
virus-induced leak. Finally, a caspase assay was used to
determine if PIC-infected endothelial cells have activated
caspases; and determine if vascular leak inhibitors alter
the levels of these caspases.
Materials and methods
Cells and Virus
The immortalized human dermal microvascular endothe-
lial cell line (HMEC-1) was provided by Edward Ades at
the United States Centers for Disease Control and Preven-
tion (CDC, Atlanta GA) [19]. Cells were maintained in
Clonetics Endothelial Growth Medium (EGM-MV) sup-
plemented with hydrocortisone, human endothelial
growth factor, fetal bovine serum, vascular endothelial
growth factor, human fibroblast growth factor-B, insulin-
like growth factor, ascorbic acid, gentamicin and ampho-
tericin-B. Pichinde (PIC) virus (designated CoAn 3739)
was obtained from ATCC, propogated in Vero cells and
titered by plaque assay using standard methods. Mouse
immune ascites fluid (MIAF) to PIC was obtained from
the University of Texas Medical Branch.
Indirect Immunofluorescence
HMEC-1 cells were grown to confluence on collagen-
coated glass chamber slides and infected with PIC at a
multiplicity of infection of 1.0. After 72 hrs, cells were
fixed with 10% paraformaldehyde in PBS at 4°C for 10
min, and washed with PBS. A 10 min incubation with
NH4Cl was used to reduce background fluorescence. Cells
were permeabilized with 0.01% TX-100 for 15 min and
subsequently blocked with 8% heat-inactivated goat
serum diluted in PBS. Primary antibody concentration
used was 1:200. A goat anti-mouse Alexa-Fluor 488
(Molecular Probes) secondary antibody was used at a con-
centration of 1:400. Prolong gold anti-fade with DAPI was
used as an overlay, then covered with a coverslip. Visuali-
zation was done using a Zeiss AxioPlan 2 fluorescent
microscope.
Transendothelial Resistance (TEER) Assay
Electrical resistance across a monolayer of HMEC-1 cells
was measured using the Endohm chamber and volt-ohm
meter (World Precision Instruments). Cells were grown
on 6 mm collagen-coated polycarbonate membrane
inserts (Corning) with 0.1 ml media in the upper chamber
and 0.6 ml media in the lower chamber. This system con-
tains two concentric electrodes, one in the bottom of the
Endohm chamber and the other attached to the cap. Volt-
age is measured by the upper electrode relative to the bot-
tom electrode. Therefore, resistance can be measured in a
reproducible manner. Blank measurements were taken
using a membrane insert with media and no cells. Resist-
ance measurements were corrected for the area of the
membrane insert and blank measurements using the fol-
lowing formula (Rexp-Rb)*0.33 cm2. Once cells had
reached confluency, indicated by a constant resistance
measurement, cells were infected with PIC at a multiplic-
ity of infection (MOI) 0.1, 1 or 3. Resistance measure-
ments were taken every 24 hours. Permeability inhibition
assays were conducted according to the same protocol
with the inhibitor added prior to virus infection.
iNOS RT-PCR
RNA from PIC-infected HMEC-1s was isolated using Tri-
zol (Invitrogen) according to the manufacturers' protocol.
Real-time PCR was conducted using the iCycler (BioRad)
with the iScript SYBR Green RT-PCR kit (BioRad). 1 μl of
extracted RNA was added to 25 μl of master mix, 1 μl of
reverse transcriptase, and 30 nM of each forward and
reverse primer. Nuclease-free water was added to bring the
total volume up to 50 μl.
The primer set used for the human inducible nitric oxide
synthase (iNOS) gene was synthesized from sequences
published in the literature [20-22]. The primer sequences
for iNOS are: 5'-TCTTGGTCAAAGCTGTGCTC-3' (forward
primer) and 5'-CATTGCCA-AACCTACTGGTC-3' (reverseVirology Journal 2009, 6:162 http://www.virologyj.com/content/6/1/162
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primer). The PCR reaction protocol includes a cDNA syn-
thesis step (50°C, 10 min) followed by reverse tran-
scriptase inactivation (95°C, 5 min); 40 PCR cycles
(95°C, 10 sec and 55°C, 30 sec) followed by melt curve
analysis. Fold up- or down-regulation was calculated
using the ΔΔCt method using Ct values from the iNOS and
GAPDH (Qiagen) primer assay.
Quantitation of TNF-α and Nitric Oxide
HMEC-1 cells were grown to confluency and infected with
PIC at an MOI of 1. Supernatants of HMEC-1 cell cultures
were collected at 24, 48, 72, and 96 hrs post infection. The
detection and quantitation of TNF-α was determined
using an enzyme-linked immunosorbent assay kit (BD).
ELISA assays were conducted according to the manufac-
turers' instructions. Detection and quantitation of nitric
oxide was conducted on cell culture supernatants using
Griess reagent (Invitrogen) (0.5% sulfanilamide, 0.05%
N-(1-napthyl) ethylenediamine dihydrochloride in 2.5%
H3PO4) in equal volumes. Absorbance was measured at
540 nm.
Caspase Activation
Apoptosis was assessed by caspase-3/7 activation using
the Apo-ONE Homogeneous Caspase-3/7 Assay kit
(Promega). Briefly, confluent HMEC-1 cells were treated
with an inhibitor and subsequently infected with PIC at
an MOI of 1. Cells were incubated for 72 hrs. The cells
were then lysed using a bifunctional cell lysis/activity
buffer containing a profluorescent caspase-3/7 substrate.
After incubation for 1.5 hours, fluorescence was measured
at an excitation wavelength of 485 nm and an emission
wavelength of 535 nm.
Results
Susceptibility of HMEC-1s to PIC infection
Before determining the effects of PIC infection on
endothelial cell barrier function, it was necessary to dem-
onstrate HMEC-1 cell susceptibility to PIC infection in
vitro. PIC antigen was detected by indirect immunofluo-
rescence assay (IFA) using PIC specific antibody in the
cytoplasm of infected cells (Fig. 1A). This is the first report
to our knowledge of PIC infection of human endothelial
cells.
Effects of PIC infection on HMEC-1 permeability
To investigate the effect of viral infection on endothelial cell
permeability, HMEC-1s were grown to confluence on
porous membrane inserts and subsequently infected with
PIC. Permeability was measured using the TEER assay,
which measures electrical resistance across a monolayer of
endothelial cells. HMEC-1s infected with PIC at MOIs of 1
and 3 demonstrate a time dependent increase in PIC-
induced permeability with a maximum reaching 60% 96 h
post-infection. Infection of PIC at an MOI of 0.1 induced a
maximum 15% increase in permeability 48 h post-infec-
tion (Fig. 2).
NO and TNF-α Production by PIC-infected HMEC-1
The protective role of low concentrations of NO in the
vascular endothelium has been previously demonstrated
[14,15,17]. To quantify the amount of NO produced by
PIC-infected HMEC-1s, levels of nitrite/nitrate were deter-
mined by the addition of Griess reagent to cell culture
supernatants. There is a statistically significant increase in
NO by 48 h post-infection; increasing in supernatants col-
lected at 72 and 96. These results are confirmed by RT-
PCR results indicating an upregulation of the iNOS gene
(Fig. 3A).
Endothelial cell susceptibility to PIC infection Figure 1
Endothelial cell susceptibility to PIC infection. HMEC-
1 cells were seeded on collagen-coated chamber slides 
infected with PIC (A) at an MOI of 1, or mock infected (B), 
and incubated 72 hrs. Cells were indirectly immunostained 
with a PIC MIAF and an anti-mouse Ig-FITC. Magnification 
63×.
Time dependence of PIC-induced permeability Figure 2
Time dependence of PIC-induced permeability. PIC 
induced permeability was quantified using the TEER assay. 
HMEC-1 cells were seeded onto collagen-coated membrane 
inserts and infected with PIC at MOI's of 0.1, 1, 3 or mock-
infected. Each experimental condition was performed in trip-
licate. Results are expressed at % increase in permeability 
over basal permeability levels.Virology Journal 2009, 6:162 http://www.virologyj.com/content/6/1/162
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Because the production of TNF-α is a prominent feature in
PIC-infected guinea pigs, the ability of PIC to induce TNF-
α in HMEC-1 was assayed by ELISA. There was no signifi-
cant increase in the amount of TNF-α produced by PIC-
infected compared to mock-infected controls (Fig. 3B)
supporting our hypothesis that other cell types, such as
macrophages or dendritic cells, are responsible for the
production of TNF-α in PIC infection.
Effect of L-NAME on PIC-induced HMEC-1 permeability
The nitric oxide synthase inhibitor, N (G)-nitro-L-arginine
methyl ester (L-NAME), was evaluated for its effects on PIC
infected EC barrier function loss using the TEER assay. 10
nM of L-NAME added prior to PIC infection was sufficient
to inhibit the increase in permeability induced by PIC to
less than 2% (Fig. 4). This supports a significant role for NO
in the increase in PIC-induced leak in HMEC-1.
Effect of NO and L-NAME on PIC viral dynamics
In order to determine the effect of NO production and
inhibition on PIC replication in HMEC-1, supernatants
from PIC-infected HMEC-1s that were treated with L-
NAME were assayed for viral titer by plaque assay. There
was no significant difference in the viral load of PIC in
HMEC-1 indicating that NO production by infected EC
did not have a protective role or limit PIC infection in
HMEC-1 (Fig. 5).
Effect of PIC on caspase activation
Because the production of NO by PIC-infected HMEC-1s
may create a cytotoxic environment, causing cells to
undergo apoptosis ultimately leading to endothelial cell
monolayer permeability changes, an examination of path-
ways associated with apoptosis was performed. Fluores-
cent detection of activated caspases indicates PIC induces
an increase in activated caspases-3 and -7 at MOIs of 1 and
10 (Fig. 6). Addition of L-NAME at concentrations that
block PIC-induced leak did not reduce the levels of acti-
vated caspases in HMEC-1. These results support other
mechanisms of caspase activation, and not NO produc-
tion in PIC-infected EC.
Discussion
Lassa fever, the most prominent VHF of the Arenaviridae
family, causes significant morbidity and mortality in West
Nitric oxide and TNF-α quantitation in PIC-infected HMEC-1  supernatants Figure 3
Nitric oxide and TNF-α quantitation in PIC-infected 
HMEC-1 supernatants. Supernatants collected from 
HMEC-1 cells infected at an MOI of 1 were assayed for 
nitrate/nitrite using Griess reagent (A, columns) as described 
above. Fold upregulation of the iNOS gene was determined 
by quantitative RT-PCR (A, line). TNF-α was assayed by 
ELISA. Each bar represents the mean of 3 independent 
experiments. * represents p < 0.05 when compared to 
mock-infected controls.
Effect of L-NAME on PIC-induced permeability Figure 4
Effect of L-NAME on PIC-induced permeability. Prior 
to PIC infection, L-NAME was added to HMEC-1 cells at a 
concentration of 10 nM. Permeability was quantified as 
described above using the TEER assay. * represents p < 0.05 
when compared to virus-infected HMEC-1.Virology Journal 2009, 6:162 http://www.virologyj.com/content/6/1/162
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Africa. Lassa virus, along with Junin, Machupo, Guanarita,
and Sabia, are considered Category A bioterrorism agents
by the CDC. These viruses require BSL-4 containment that
makes research on these viruses labor-intensive. PIC rep-
resents a non-pathogenic (for humans) model of arenavi-
rus infection, which requires BSL-2 containment facilities.
PIC virus adapted to strain 13 guinea pigs show patholog-
ical similarities with arenavirus-induced hemorrhagic dis-
ease, further supporting its utility as a model for
evaluation of potential antiviral or other therapeutic tar-
gets for the treatment of virus-induced hemorrhagic dis-
ease.
Previously published studies demonstrate PIC-infected
guinea pigs express elevated levels of TNF-α [3]. Evalua-
tion of supernatant fluids from PIC-infected HMEC-1 by
ELISA showed no increase in production of TNF-α com-
pared to uninfected HMEC-1. These results indicate a
non-TNF-α dependant mechanism of leak in PIC infected
HMEC-1. Previous studies show PIC infection of murine
macrophages leads to NF-κB activation, and the produc-
tion of TNF-α and IL-6 [23]. Arenaviruses have been dem-
onstrated to be macrophage tropic in vivo, we propose
that macrophages as a primary source of TNF-α in PIC
infection.
We have demonstrated PIC infection of human endothe-
lial cells; and that PIC infection of HMEC-1s induces the
production of NO. Analysis of the iNOS gene indicates an
upregulation that correlates with NO levels produced. Ele-
vated levels of NO have also been noted in Junin infection
of endothelial cells, further supporting the utility of PIC
infected HMEC-1 as a model for arenavirus-induced VHF.
PIC induces an increase in permeability measured by the
TEER assay. This increase in permeability can be abro-
gated with the addition of L-NAME, the NO synthase
inhibitor. This shows that levels of NO produced by PIC-
infected HMEC-1s are pathogenic and compromise
endothelial cell barrier function.
NO has been shown to play a role in host defense against
a variety of microbial pathogens: bacteria, parasites, and a
variety of viruses [24]. Some of these viruses include influ-
enza, coxsackievirus, rhinovirus, and vaccinia virus [25-
28]. Studies conducted using the NO donor, SNAP, dem-
onstrated that NO inhibits the synthesis of viral RNA in
influenza virus infected cells, an early event in influenza
replication. Comparing viral titers quantitated by plaque
assay, it was determined that there was no significant
change in viral titer when L-NAME was added to PIC-
infected HMEC-1s. Studies conducted using lymphocytic
choriomeningitis virus (LCMV), another arenavirus, show
there no difference in viral kinetics, viral clearance, or the
production of cytokines and chemokines in LCMV-
infected iNOS knockout mice were compared with LCMV-
infected wild type mice [29].
NO is a unique radical that demonstrates pro-apoptotic or
anti-apoptotic effects [15]. A fluorometric assay was used
to quantitate activated caspases that indicated an increase
in PIC infected HMEC-1s. However, L-NAME was not able
to significantly impact these levels. This demonstrates that
the increase in NO is not responsible for the increase in
activated caspases due to PIC infection.
Effect of L-NAME on PIC viral dynamics Figure 5
Effect of L-NAME on PIC viral dynamics. Supernatants 
from PIC-infected HMEC-1s treated with L-NAME were 
assayed for PIC by standard plaque assay. Each timepoint 
represents the mean of two experiments.
Effect of PIC infection on caspase activation Figure 6
Effect of PIC infection on caspase activation. HMEC-1s 
were infected with PIC at MOIs of 0.1, 1, 10 (n = 3). In addi-
tion, 10 nM of L-NAME was added prior to PIC MOI = 1 
infection (n = 5). Caspase activation was fluorescently 
detected 72 h post-infection. * represents p < 0.05 when 
compared with mock-infected controls. HMEC-1s treated 
with L-NAME and infected with PIC were tested for signifi-
cance versus HMEC-1s infected with PIC MOI = 1; results 
were not considered significant.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Virology Journal 2009, 6:162 http://www.virologyj.com/content/6/1/162
Page 6 of 6
(page number not for citation purposes)
In conclusion, these studies identify specific virus/cell
interactions leading to vascular permeability in PIC
infected HMEC-1. We demonstrate HMEC-1 cells are sus-
ceptible to PIC infection. PIC infection induces the pro-
duction of NO. NO was determined to be an important
factor in the loss of endothelial cell monolayer integrity.
Inhibition of NO activity with L-NAME supported the role
of NO in HMEC-1 leak. These studies will be critical as an
in vitro model of VHF pathogenesis and to identify mech-
anisms of vascular leak and to identify potential inhibi-
tors of VHF-induced leak in an effort to alleviate the
severity of VHF.
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